Safety and efficacy of anti-PD1 therapy for metastatic melanoma and non-small cell lung cancer in patients with concurrent viral hepatitis

被引:0
作者
Kothapalli, A. [1 ]
Khattak, M. [2 ]
机构
[1] Fiona Stanley Hosp, Dermatol, Perth, WA, Australia
[2] Fiona Stanley Hosp, Med Oncol, Perth, WA, Australia
关键词
PEMBROLIZUMAB; IPILIMUMAB;
D O I
暂无
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
引用
收藏
页码:79 / 79
页数:1
相关论文
共 7 条
  • [1] Clinical experience with ipilimumab 3 mg/kg: real-world efficacy and safety data from an expanded access programme cohort
    Ascierto, Paolo A.
    Simeone, Ester
    Sileni, Vanna Chiarion
    Pigozzo, Jacopo
    Maio, Michele
    Altomonte, Maresa
    Del Vecchio, Michele
    Di Guardo, Lorenza
    Marchetti, Paolo
    Ridolfi, Ruggero
    Cognetti, Francesco
    Testori, Alessandro
    Bernengo, Maria Grazia
    Guida, Michele
    Marconcini, Riccardo
    Mandala, Mario
    Cimminiello, Carolina
    Rinaldi, Gaetana
    Aglietta, Massimo
    Queirolo, Paola
    [J]. JOURNAL OF TRANSLATIONAL MEDICINE, 2014, 12
  • [2] PD-1 Blockade in Advanced Melanoma in Patients with Hepatitis C and/or HIV
    Davar, Diwakar
    Wilson, Melissa
    Pruckner, Chelsea
    Kirkwood, Johnm M.
    [J]. CASE REPORTS IN ONCOLOGICAL MEDICINE, 2015, 2015
  • [3] Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial
    El-Khoueiry, Anthony B.
    Sangro, Bruno
    Yau, Thomas
    Crocenzi, Todd S.
    Kudo, Masatoshi
    Hsu, Chiun
    Kim, Tae-You
    Choo, Su-Pin
    Trojan, Jorg
    Welling, Theodore H., III
    Meyer, Tim
    Kang, Yoon-Koo
    Yeo, Winnie
    Chopra, Akhil
    Anderson, Jeffrey
    dela Cruz, Christine
    Lang, Lixin
    Neely, Jaclyn
    Tang, Hao
    Dastani, Homa B.
    Melero, Ignacio
    [J]. LANCET, 2017, 389 (10088) : 2492 - 2502
  • [4] Jazirehi AR, 2016, AM J CANCER RES, V6, P2117
  • [5] Pembrolizumab versus Ipilimumab in Advanced Melanoma
    Robert, Caroline
    Schachter, Jacob
    Long, Georgina V.
    Arance, Ana
    Grob, Jean Jacques
    Mortier, Laurent
    Daud, Adil
    Carlino, Matteo S.
    McNeil, Catriona
    Lotem, Michal
    Larkin, James
    Lorigan, Paul
    Neyns, Bart
    Blank, Christian U.
    Hamid, Omid
    Mateus, Christine
    Shapira-Frommer, Ronnie
    Kosh, Michele
    Zhou, Honghong
    Ibrahim, Nageatte
    Ebbinghaus, Scot
    Ribas, Antoni
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2015, 372 (26) : 2521 - 2532
  • [6] Pooled Analysis of Long-Term Survival Data From Phase II and Phase III Trials of Ipilimumab in Unresectable or Metastatic Melanoma
    Schadendorf, Dirk
    Hodi, F. Stephen
    Robert, Caroline
    Weber, Jeffrey S.
    Margolin, Kim
    Hamid, Omid
    Patt, Debra
    Chen, Tai-Tsang
    Berman, David M.
    Wolchok, Jedd D.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (17) : 1889 - U48
  • [7] Pembrolizumab for the treatment of PD-L1 positive advanced or metastatic non-small cell lung cancer
    Thu Oanh Dang
    Ogunniyi, Adebayo
    Barbee, Meagan S.
    Drilon, Alexander
    [J]. EXPERT REVIEW OF ANTICANCER THERAPY, 2016, 16 (01) : 13 - 20